NCT07109414 2026-03-09
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
Novita Pharmaceuticals, Inc.
Phase 2/3 Active not recruiting
Novita Pharmaceuticals, Inc.
Daiichi Sankyo
GE Healthcare
Sutro Biopharma, Inc.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
AB Science
Pierian Biosciences
Merck Sharp & Dohme LLC
Sanofi
Pierian Biosciences
Menarini Group